Day: January 30, 2024

NORWOOD, Mass., Jan. 30, 2024 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) (“Corbus” or the “Company”), a precision oncology company with a diversified portfolio, today announced that it plans to offer and sell shares of its common stock or, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock in an underwritten registered public offering. All of the securities in the offering are to be sold by Corbus. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering. Corbus intends to use the net proceeds of the proposed underwritten offering to fund the clinical development of its pipeline and for working capital and other general corporate purposes. Jefferies...

CALGARY, Alberta, Jan. 30, 2024 (GLOBE NEWSWIRE) — Wilmington Capital Management Inc. (“Wilmington” or the “Corporation”) is pleased to announce that its Board of Directors has determined that the embedded value of Wilmington’s marinas investment, including Maple Leaf Marinas Limited Partnership (“MLM”), has been substantially realized. As a result, the Corporation will seek to effect a sale of its approximate 17.32% interest therein (along with its corresponding general partner interest) in accordance with the MLM limited partnership agreement. Subject to applicable laws and after giving consideration to its ongoing liquidity needs, the Corporation anticipates that it will effect a distribution to its shareholders out of proceeds received in connection with any such sale. Executive Officers of the Corporation are available at...

HOUSTON, TEXAS, Jan. 30, 2024 (GLOBE NEWSWIRE) — Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) announced today that it has signed an equity purchase agreement to sell its Activ Nutritional, LLC subsidiary, which owns the Viactiv® brand and business, to Doctor’s Best Inc. (“Doctor’s Best”), a wholly-owned subsidiary of Kingdomway USA Corp. (“Kingdomway”), for gross cash consideration of $17.2 million, payable in full at closing. The transaction has been approved by the respective Boards of Directors of Guardion and of Doctor’s Best, and remains subject to normal and customary closing conditions, including approval of the transaction by the Company’s stockholders at a forthcoming Special Meeting of Stockholders. Assuming requisite approval by the Company’s stockholders, the transaction is expected to...

Conference call to follow on February 7, 2024 at 9:00am ET NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) — StoneX Group Inc. (NASDAQ: SNEX) today announced that it will release its fiscal 2024 first quarter results after the market close on Tuesday, February 6, 2024. Management will host a conference call on Wednesday, February 7, 2024 at 9:00 a.m. Eastern Time to review the Company’s 2024 fiscal first quarter results. A live web cast of the conference call as well as additional information to review during the call will be made available in PDF form at https://www.stonex.com. Participants can also access the call via https://register.vevent.com/register/BIa273b443d0ab4ea585be27e0b2dcd79a approximately ten minutes prior to the start time. Participants may preregister for the conference call here. For those who cannot access the...

Conference Call Scheduled for Wednesday, January 31, 2024 at 8:30 AM ET DUBLIN, Ireland, Jan. 30, 2024 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, will host an investor call on Wednesday, January 31 at 8:30 AM ET to provide an update on business operations. Conference Call Dial-In & Webcast InformationDate: Wednesday, January 31, 2024Time: 8:30 AM ETUnited States: 1-877-407-0784International: 1-201-689-8560Conference ID: 13744109Webcast: Click Here for WebcastCallMe™: Click Here for CallMe FeatureAbout Trinity Biotech Trinity Biotech develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care...

The RCN Convocation 2024 was a testament to the commitment of RCN and Ohmyhome in fostering excellence within the real estate industry and inspiring the next generation of real estate salespeople.SINGAPORE, Jan. 30, 2024 (GLOBE NEWSWIRE) — Ohmyhome Ltd. (NASDAQ: OMH, “Ohmyhome”), a one-stop-shop property technology platform providing end-to-end property solutions and services to buy, sell, rent, and renovate homes, as well as property management services for condominiums in Singapore, collaborated with Real Centre Network (RCN), the leading RES Course Providers in Singapore for over a decade, to host the first-ever RCN Convocation 2024 on January 20, 2024. This milestone event was sponsored and supported by many industries leading organizations including Ohmyhome, Far East Organisation, OrangeTee & Tie, ERA Realty Network,...